AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Google’s $32 billion acquisition of Wiz draws antitrust attention
2
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
3
Cyberattacks against Israel surge 700% in two days, says Radware
4
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
5
Andreessen Horowitz targets elite IDF alumni for startup accelerator
More news

Galmed

4 stories about Galmed
אלן בהרב גלמד

Israeli pharmaceutical company Galmed raises $18 million during trial of its main product

22.02.21|James Spiro
The Nasdaq-traded company has developed a drug to treat fatty liver
שרון מלכה MediWound

Biomed at the focus of new Israel-UAE business cooperation

25.10.20|CTech
New cross-business initiative is led by Tel-Aviv based consultancy firm Kamir Strategy and UAE-based PR firm Cosmopole
נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich
Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
נאסד"ק וול סטריט

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering

04.04.18|Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014